会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS
    • 吡咯里酮衍生物,低聚物和聚合物
    • EP3194365A1
    • 2017-07-26
    • EP15839322.3
    • 2015-09-14
    • Nanosynthons LLC
    • TOMALIA, Donald A.HEDSTRAND, David M.NIXON, Linda S.
    • C07D207/28C07D207/277
    • A61K49/0021C07D207/277C07D207/28C07D403/14C09B13/00
    • Simple organic structures, organic/inorganic polymers, and other substrates have been made, all of which have at least one pyrrolidone moiety present, and found to exhibit low toxicity, low complement activation features and may be used to reduce protein interactions with drug conjugates while enhancing in vivo residency times for these conjugates when used as an injectable composition; thus these compounds can be used as substitutes for PEG in PEGaylation. Surprisingly, these compounds also exhibit unique intrinsic fluorescence (IF) or non-traditional fluorescence (NTF) properties that currently cannot be explained by traditional photochemistry and fluorescence paradigms are described. These compounds have a variety of applications such as in cellular imaging, gene transfection, bio-diagnostics, biosensing, fluorescence directed surgical resections, drug delivery, forensics, environmental diagnostics, mineral/gemstone characterization, counterfeit goods detection, tracer studies related to liquid/water flow, oil field enhancements and diagnostics, prevention of photo-bleaching, and LED display enhancements and others.
    • 已经制备了简单的有机结构,有机/无机聚合物和其他底物,其全部具有至少一种吡咯烷酮部分,并且发现其具有低毒性,低补体活化特征并且可以用于减少与药物缀合物的蛋白质相互作用,同时 当用作可注射组合物时增强这些缀合物的体内驻留时间; 因此这些化合物可以用作PEG化中的PEG的替代物。 令人惊讶的是,这些化合物还表现出独特的内在荧光(IF)或非传统荧光(NTF)性质,目前无法用传统的光化学来解释,并描述了荧光范式。 这些化合物在细胞成像,基因转染,生物诊断,生物传感,荧光定向手术切除,药物递送,法医学,环境诊断,矿物/宝石表征,假冒商品检测,与液体/ 水流量,油田增强和诊断,防止光漂白和LED显示增强等。